Bafna Pharmaceuticals Limited (BOM:532989)
India · Delayed Price · Currency is INR 132.50
-2.50 (-1.85%)
At close: Apr 22, 2026
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 3.23 billion as of April 22, 2026. Its market cap has increased by 75.84% in one year.
Market Cap
3.23B
Enterprise Value
3.55B
Revenue
1.47B
Ranking
n/a
PE Ratio
33.41
Stock Price
132.50
Market Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 3.23B, an increase of 29,563.04%. That is a compound annual growth rate of 152.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 3.23B | -9.47% |
| Dec 31, 2025 | 3.57B | 91.03% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZIM Laboratories | 4.24B |
| Albert David | 4.06B |
| Medico Remedies | 3.34B |
| Medicamen Biotech | 3.29B |
| Kerala Ayurveda | 3.20B |
| Trident Lifeline | 2.96B |
| Sat Kartar Life | 2.91B |
| Everest Organics | 2.60B |